From left to right: Mr. Lian-Chwan Yang, President of Synbio Tech Inc., and Mr. San-Land Young, CEO of Synbio Tech Inc., receiving the 21st Taiwan National Innovation Award for TWK10®.
Synbio Tech Inc. (1295:Taipei) proudly announces that its flagship probiotic strain, TWK10® (Lactiplantibacillus plantarum TWK10), has received two prestigious honors: the Gold Medal at the 2025 Malaysia Technology Expo (MTE) and the 21st Taiwan National Innovation Award. These dual recognitions underscore Synbio Tech's commitment to scientific excellence and reinforce its position as a pioneer in the field of healthy aging.
Global Recognition for Innovation in Healthy Aging
At the 24th Malaysia Technology Expo (MTE) 2025, TWK10® stood out among 425 innovative technologies and products from more than 15 countries, including the United States, the United Kingdom, Japan, Singapore, Indonesia, and Egypt. The MTE is one of Asia's most influential platforms for technological innovation. TWK10®'s groundbreaking application in healthy aging earned it the coveted Gold Medal, affirming its scientific excellence and global relevance.
Scientific studies have demonstrated that TWK10® significantly improves age-related muscle weakness, bone loss, and cognitive decline. By modulating the gut microbiome, TWK10® promotes healthy aging, positioning it as a leading innovation in the global fight against age-associated health challenges. These findings have been published in top-tier international journals, gaining widespread academic recognition.
“TWK10® represents a breakthrough in probiotic science, providing innovative solutions for healthy aging through gut microbiome modulation,” said Mr. San-Land Yang, Chief Executive Officer of Synbio Tech Inc. “This international recognition is a testament to our dedication to scientific innovation and global health advancement.”
National Innovation Award: A Testament to Market Potential and Technological LeadershipIn addition to its international acclaim, TWK10® has also been honored with the 21st Taiwan National Innovation Award—one of the country's highest accolades in biotechnology. This award recognizes products and enterprises demonstrating excellence in technological innovation, application, and market potential.
TWK10® has successfully redefined the boundaries of traditional probiotic applications. Backed by rigorous scientific research and outstanding global market performance, it has strengthened Taiwan's standing in the global probiotic industry. This achievement not only highlights Synbio Tech's commitment to scientific rigor but also underscores Taiwan’s growing influence in the biotechnology sector.
“Receiving these two prestigious awards is more than an honor—it is a validation of Synbio Tech's unwavering commitment to research excellence and global health innovation,” Mr. Yang added. “We will continue to advance clinical research, expand global partnerships, and explore new market opportunities to elevate Taiwan's biotech industry on the international stage.”
Driving Global Health Innovation
We are dedicated to advancing the science of probiotics and postbiotics. The dual recognition of TWK10® underscores the company's leadership in innovative R&D and highlights its strong position in the competitive global market.
Looking forward, Synbio Tech will continue to uphold its mission of “Changing Lives with Probiotics,” focusing on scientific advancement, expanding innovative applications, and contributing to the development of the global health industry.
References
- Lee, C. C., Liao, Y. C., Lee, M. C., Lin, K. J., Hsu, H. Y., Chiou, S. Y., ... & Watanabe, K. (2021). Lactobacillus plantarum TWK10 attenuates aging-associated muscle weakness, bone loss, and cognitive impairment by modulating the gut microbiome in mice. Frontiers in Nutrition, 8, 708096.
- Lee, M. C., Tu, Y. T., Lee, C. C., Tsai, S. C., Hsu, H. Y., Tsai, T. Y., ... & Huang, C. C. (2021). Lactobacillus plantarum TWK10 improves muscle mass and functional performance in frail older adults: A randomized, double-blind clinical trial. Microorganisms, 9(7), 1466.
- Synbio Tech Inc. (2023). Lactobacillus plantarum TWK10 composition for improving aging-related conditions (Japanese Patent No. JP7410569B2).
- Synbio Tech Inc. (2022). Lactobacillus plantarum TWK10 composition for improving aging-related conditions (U.S. Patent Application No. US20220072070A1).